IAN CHIU: Open Payments
NPI 1477147585 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,094 in 43 payments from 13 companies in 2025. Trend: 2023 $549 · 2024 $1,532 · 2025 $12,094
Speaker / faculty: $4,125Consulting: $4,046Food & beverage: $2,029Travel & lodging: $1,894
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $5,727 |
| Apellis Pharmaceuticals, Inc. | 6 | $4,993 |
| Travere Therapeutics, Inc. | 6 | $506 |
| Alexion Pharmaceuticals, Inc. | 3 | $185 |
| Novartis Pharmaceuticals Corporation | 3 | $174 |
| Aurinia Pharma U.S., Inc. | 1 | $149 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Calliditas Therapeutics US Inc. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 3 | $42 |
Products named: TAVNEOS, Filspari, ULTOMIRIS, UPLIZNA, Vanrafia, LUPKYNIS, TARPEYO, BENLYSTA.
Industry payments across NY — which companies pay providers there.
